Eosinophilia and Hypereosinophilic Disorders – Update on Etiopathogeny, Classification and Clinical Approach

1. MOQBEL R, LACY P, ADAMKO DJ, ODEMUYIWA SO. Biology of Eosinophils. In Middleton’s Allergy Principles and Practice, Seventh Edition. Cap 18, p. 295-310.10.1016/B978-0-323-05659-5.00018-8Search in Google Scholar

2. LACY P, MOQBEL R. Immune effector functions of eosinophils in allergic airway inflammation. Curr Opin Allergy Clin Immunol 2001; 1:79-84.10.1097/00130832-200102000-00014Search in Google Scholar

3. VALENT P, KLION AD, ROSENWASSER LJ, et al. ICON (International Consensus ON): Eosinophilic Disorders. Consensus document. WAO Journal 2012; 5:174-181.Search in Google Scholar

4. GOTLIB J. World Health Organization – defined eosinophilic disorders: 2014 update on diagnosis, risk stratification and management. American Journal of Hematology 2014; 89(3):326-37.10.1002/ajh.2366424577808Search in Google Scholar

5. GLEICH GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-63.10.1067/mai.2000.10571210756213Search in Google Scholar

6. HOGAN SP, ROSENBERG HF, MOQBEL R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:709-50.10.1111/j.1365-2222.2008.02958.x18384431Search in Google Scholar

7. WOERLY G, ROGER N, LOISEAU S, et al. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gama: inhibition by immunoglobulin complexes. J Exp Med 1999; 190:487-495.10.1084/jem.190.4.487219559910449520Search in Google Scholar

8. PARDANANI A, PATNAIK MM, TEFFERI A. Eosinophilia: Secondary, clonal and idiopathic. Br J Haematol 2006; 133:468-92.10.1111/j.1365-2141.2006.06038.x16681635Search in Google Scholar

9. GOTLIB J, COOLS J. Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia 2008; 22: 1999-2010.10.1038/leu.2008.28718843283Search in Google Scholar

10. SIMON HU, ROTHENBERG ME, BOCHNER BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010; 126: 45-49.10.1016/j.jaci.2010.03.042340002420639008Search in Google Scholar

11. BAIN BJ, GILLILAND DG, HORNY HP, et al. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008, p. 68-73.Search in Google Scholar

12. VALENT P, KLION AD, HORNY HP, ROUFOSSE F, GOTLIB J, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130:607-612.10.1016/j.jaci.2012.02.019409181022460074Search in Google Scholar

13. CHUSID MJ, DALE DC, WEST BC, WOLF SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975; 54: 1-27.10.1097/00005792-197501000-00001Search in Google Scholar

14. KLION AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology 2005; 209-14.10.1182/asheducation-2005.1.20916304382Search in Google Scholar

15. VAGLIO A, BUZIO C, ZWERINA J. Eosinophilic granulomatosis with polyangiitis (Churg – Strauss): state of the art. Allergy 2013; 68: 261-73.10.1111/all.1208823330816Search in Google Scholar

16. LEFEBVRE C, BLETRY O, DEGOULET P, et al. Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris) 1989; 140:253-7.Search in Google Scholar

17. PODJASEK JC, BUTTERFIELD JH. Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. Leuk Res 2013; 37:392-5.10.1016/j.leukres.2012.12.01623332454Search in Google Scholar

18. KLION AD. How I treat hypereosinophilic syndromes. Blood 2009;114(18): 3736-41.10.1182/blood-2009-07-143552277348819692700Search in Google Scholar